DesignMedix.com is a drug development company fighting drug resistance.
DesignMedix
Excerpted from the website:
- DesignMedix, Inc. is a drug development company focused on overcoming drug resistance, one of the major challenges impacting human health and drug development today. The DesignMedix approach offers both a mechanism to overcome resistance, and the ability to develop an ongoing series of novel drugs. DesignMedix has designed and synthesized a library of novel candidate drugs called reverse chloroquines (or RCQ’s) to combat several important infectious diseases. In the companies most advance drug development program, lead compounds have been shown to overcome malaria drug resistance in human red blood cells in vitro, and to provide a cure in animal models. Work on overcoming drug resistance in other diseases is ongoing.
Contact
Languages
English